Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Sales | 202,534 | 152,784 | 197,523 | 231,351 | 215,059 |
| Cost of Goods | 75,221 | 59,691 | 73,896 | 86,976 | 82,383 |
| Gross Profit | 127,313 | 93,093 | 123,627 | 144,375 | 132,676 |
| Operating Expenses | 106,294 | 64,164 | 107,416 | 132,959 | 124,321 |
| Operating Income | 21,240 | 29,620 | 17,107 | 12,392 | 8,738 |
| Interest Expense | 5,472 | 5,531 | 5,912 | 5,382 | 5,142 |
| Other Income | 2,022 | -641 | -238 | 176 | 379 |
| Pre-tax Income | 17,790 | 23,448 | 10,957 | 7,186 | 3,975 |
| Income Tax | 6,058 | 3,174 | 1,967 | 2,361 | 1,769 |
| Net Income Continuous | 11,732 | 20,274 | 8,990 | 4,825 | 2,206 |
| Net Income Discontinuous | -3,348 | -3,108 | 817 | N/A | N/A |
| Net Income | $8,384 | $17,166 | $9,807 | $4,825 | $2,206 |
| EPS Basic Total Ops | 0.13 | 0.26 | 0.16 | 0.08 | 0.04 |
| EPS Basic Continuous Ops | 0.18 | 0.31 | 0.14 | 0.07 | 0.03 |
| EPS Basic Discontinuous Ops | -0.05 | -0.06 | 0.02 | N/A | N/A |
| EPS Diluted Total Ops | 0.13 | 0.27 | 0.15 | 0.08 | 0.04 |
| EPS Diluted Continuous Ops | 0.18 | 0.31 | 0.14 | 0.07 | 0.03 |
| EPS Diluted Discontinuous Ops | -0.05 | -0.04 | 0.01 | N/A | N/A |
| EBITDA(a) | $33,570 | $42,523 | $22,802 | $28,230 | $23,307 |